Kypha
1 known investors
Kypha develops clinical diagnostic tests for immune system biomarkers, particularly complement activity markers, and provides solutions for real-time immune insights across therapeutic areas. The company serves biopharma firms, clinical laboratories, and medical institutions through a network of clinical collaborators and research partners.
BiotechDeep TechHealthtechMedical Devices
Investors · 1
In the news
- Kypha - 2026 Company Profile, Team, Funding & Competitors - Tracxntracxn.com · 2021
- Kypha raises $4m to expand capabilities of Irish subsidary Biosensia – The Irish Timesirishtimes.com · 2018
- Kypha Secures $4M Series A Funding to Accelerate First-in-Class Diagnostic Platform Commercialization - BioSpacebiospace.com · 2018
- Kypha Secures $4M Series A Funding to Accelerate First-in-Class Diagnostic Platform Commercializationprnewswire.com · 2018
- St. Louis startup Kypha acquires medical device firm from Irelandstltoday.com · 2018
- Kypha Raises $1.5M To Bring Compact Health Diagnosis Tech To Market - Techlitechli.com · 2012